U.S. CDC advisers to review data on COVID-19 vaccine boosters
FILE PHOTO: A person receives a COVID-19 vaccine at Floyd's Family Pharmacy as cases of the coronavirus disease (COVID-19) surge in Ponchatoula, Louisiana, U.S., August 5, 2021. REUTERS/Callaghan O'Hare
(Reuters) - A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to discuss considerations for booster doses of COVID-19 vaccines, as the United States deals with increasing cases from the Delta variant of the coronavirus.
The meeting of CDC's Advisory Committee on Immunization Practices will also discuss updates on additional doses in immune compromised individuals.
Israel has already started administering a third booster shot to people aged 60 and above after the country's health ministry reported a decrease in the effectiveness of the Pfizer Inc vaccine in preventing infections and symptomatic illness.
Last month, top U.S. infectious disease expert Anthony Fauci said Americans who are immune compromised may end up needing COVID-19 vaccine booster shots.
(Reporting by Mrinalika Roy in Bengaluru)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump says renewed US campaign against Iran won't last long
- Premarket movers: Dell, GitLab surge and MongoDB tumbles
- Google avoids breakup as judge rejects ad tech sale order
Create E-mail Alert Related Categories
FDA, General News, ReutersRelated Entities
AdComSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share